Dementia drug developer Axovant climbs after $315M IPO
Shares of Axovant Sciences nearly doubled in value after the dementia drug developer said its initial public offering raised $315 million, more than Axovant had expected.
Jun 11, 2015
Archive: 11/06/2015
College students who binge drink have more delayed sleep timing, variable sleep schedules
A new study suggests that students who initiate and/or continue drinking and engage in binge drinking in college have more delayed sleep timing and more variable sleep schedules.
Jun 11, 2015
Interactions between cortical and subcortical regions important in hypersensitivity in ASD
The increased interaction between cortical and subcortical brain regions highlights the central role of hypersensitivity and other sensory symptoms in defining Autism Spectrum Disorder (ASD). This is presented in research ...
Jun 11, 2015
Study shows first signs that drug used to treat ADHD may improve cognitive difficulties for menopausal women
According to a new study, women experiencing difficulty with time management, attention, organization, memory, and problem solving - often referred to as executive functions - related to menopause may find improvement with ...
Jun 11, 2015
